Authors |
|
Abstract |
The current controversy as to the proper role of the placebo control in the evaluation of new treatments for schizophrenia requires an analysis that is sensitive to both ethical and scientific issues. Clinical equipoise, widely regarded as the moral foundation of the randomized controlled trial (RCT), requires the use of best available treatment as the control in RCT. Scientific criticisms of the use of an active control are examined and none present an insuperable barrier to the use of an active control. Indeed, scrutiny of the most recent argument for the use of placebo controls, 'assay sensitivity', suggests that the use of placebo may be the cause of the problem pointed to. Scientific, regulatory, ethical and legal advantages of the use of an active control are described. While the use of a placebo control may be acceptable in carefully defined circumstances, in most cases the use of an active control in schizophrenia research is ethically and scientifically preferable
|
Keywords | No keywords specified (fix it) |
Categories | (categorize this paper) |
Options |
![]() ![]() ![]() |
Download options
References found in this work BETA
No references found.
Citations of this work BETA
The Ethical Analysis of Risk.Charles Weijer - 2000 - Journal of Law, Medicine and Ethics 28 (4):344-361.
The Ethical Analysis of Risk.Charles Weijer - 2000 - Journal of Law, Medicine and Ethics 28 (4):344-361.
The Ethics and Science of Placebo-Controlled Trials: Assay Sensitivity and the Duhem–Quine Thesis.James Anderson - 2006 - Journal of Medicine and Philosophy 31 (1):65 – 81.
Similar books and articles
What Makes Placebo-Controlled Trials Unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
The Necessity and the Value of Placebo.Ernst A. Singer - 2004 - Science and Engineering Ethics 10 (1):51-56.
The Ethics and Science of Placebo-Controlled Trials: Assay Sensitivity and the Duhem–Quine Thesis.James Anderson - 2006 - Journal of Medicine and Philosophy 31 (1):65 – 81.
Clinical Trials: Active Control Vs Placebo — What is Ethical?Jacek Spławiński & Jerzy Kuźniar - 2004 - Science and Engineering Ethics 10 (1):73-79.
Using Empirical Data to Inform the Ethical Evaluation of Placebo Controlled Trials.Jeremy Sugarman - 2004 - Science and Engineering Ethics 10 (1):29-35.
Placebo and the Helsinki Declaration — What to Do?Bozidar Vrhovac - 2004 - Science and Engineering Ethics 10 (1):81-93.
Placebo Controls and Epistemic Control in Orthodox Medicine.Mark D. Sullivan - 1993 - Journal of Medicine and Philosophy 18 (2):213-231.
Control Theory: Placebo-Controlled Drug Trials Have Problems. Active-Controlled Drug Trials Are Not Always the Solution.Beatrice Alexandra Golomb - 2009 - American Journal of Bioethics 9 (9):67-69.
Ethical Issues in the Difference Between Placebo-Controlled and Active-Controlled Trials.Carlo Petrini - 2009 - American Journal of Bioethics 9 (9):56-58.
‘Placebos’ and the Logic of Placebo Comparison.Andrew Turner - 2012 - Biology and Philosophy 27 (3):419-432.
Placebo Treatment is Effective Differently in Different Diseases — but is It Also Harmless? A Brief Synopsis.Thomas R. Weihrauch - 2004 - Science and Engineering Ethics 10 (1):151-155.
Placebo-Controlled Studies in Schizophrenia: Ethical and Scientific Perspectives. Panel Discussion.T. M. Lemmens, P. S. Appelbaum, W. Carpenter, C. McCarthy, C. Peterson, D. Streiner & Charles Weijer - unknown
The Ethics of Sham Surgery in Parkinson's Disease: Back to the Future?Teresa Swift & Richard Huxtable - 2013 - Bioethics 27 (4):175-185.
Informed Consent and the Use of Placebo in Poland: Ethical and Legal Aspects.Piotr Zaborowski & Adam Górski - 2004 - Science and Engineering Ethics 10 (1):167-178.
Analytics
Added to PP index
2010-09-08
Total views
15 ( #694,251 of 2,498,128 )
Recent downloads (6 months)
3 ( #212,593 of 2,498,128 )
2010-09-08
Total views
15 ( #694,251 of 2,498,128 )
Recent downloads (6 months)
3 ( #212,593 of 2,498,128 )
How can I increase my downloads?
Downloads